#Fibrin Sealants Market Share
Link
The growing prevalence of cardiovascular diseases and blood disorders, increase in the number of surgical procedures as well as growing geriatric population are some of the factors driving the Fibrin Sealants Market growth during the forecast period 2022-2027.
0 notes
Text
Resuscitation Devices Market Size, Share, and Trends: Market Dynamics
"The resuscitation devices market was valued at USD 4.78 billion in 2023 and is projected to expand at a CAGR of 7.5% from 2023 to 2032, reaching USD 9.00 billion by 2032". This growth underscores substantial opportunities in this rapidly expanding, high-volume industry. The report offers a comprehensive analysis of the overall market conditions, trends, regional insights, opportunities, key players, and market segmentation, delivering crucial information for business success.
Get free Report Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/109515
The report presents detailed market segmentation, a systematic overview of key players, supply chain dynamics, consumer trends, and insights into emerging geographical markets. It provides an in-depth analysis of major market developments and competitor analysis, highlighting significant competitors to help businesses gain a comprehensive understanding of the market and products, enabling them to craft superior strategies. The team at Fortune Business Insights is committed to understanding clients' businesses and needs to deliver exceptional market research. This report is uniquely tailored to meet specific business requirements, making it highly relevant and commendable.
Resuscitation Devices Market Key Attributes:
Report Attribute
Details
Forecast Period
2024 - 2032
Estimated Market Value (USD) in 2023
USD 4.78 billion
Forecasted Market Value (USD) by 2032
USD 9.00 billion
Compound Annual Growth Rate
7.5%
Report Type
Global
Our report explores various sectors, from pharmaceuticals to medical devices, offering stakeholders actionable intelligence to navigate and thrive in this dynamic market. Whether you are a healthcare provider, investor, or policymaker, our research equips you with the knowledge necessary to make informed decisions and drive innovation in the ever-evolving healthcare sector.
Top 10 Major Competitors of the of Resuscitation Devices Market:
Koninklijke Philips N.V. (Netherlands)
Hamilton Medical (Switzerland)
Getinge AB (Sweden)
Medtronic (Ireland)
Teleflex Incorporated (U.S.)
Convatec Group PLC (U.K.)
Ambu A/S (Denmark)
Flexicare Medical Limited (U.K.)
ICU Medical (U.S.)
ZOLL Medical Corporation (Asahi Kasei) (U.S.)
Stryker (U.S.)
Resuscitation Devices Market Key Drivers:
Increasing prevalence of cardiovascular and respiratory diseases.
Rising cases of sudden cardiac arrests.
Technological advancements in resuscitation devices.
Growing awareness and training for CPR and device usage.
Expansion of emergency medical services and public access to devices.
Here are some key elements of the fibrin sealants market 2024-2030 strategy:
Define the Research Objectives The first step in the fibrin sealants market strategy is to clearly establish the research objectives. This involves pinpointing the specific questions that need to be answered and the information required. Clear objectives will steer the entire research process, ensuring the data collected is relevant and useful.
Identify the Target Market Businesses must pinpoint their target market and understand their needs, preferences, and behaviors. This involves segmenting the market based on factors such as demographics, psychographics, and geographic location. A thorough understanding of the target market allows for products, services, and marketing efforts to be effectively tailored to meet customer needs.
Select the Research Methodology Choosing the right research methodology is crucial for gathering accurate and relevant data. Various methodologies, including surveys, focus groups, and observational research, can be employed. The chosen methodology should align with the research objectives and the type of data needed.
Collect Data With the research methodology selected, data collection can commence using techniques such as online surveys, phone interviews, or in-person focus groups. Ensuring that the data collected is reliable, valid, and representative of the target market is essential for making informed decisions.
Analyze the Data After data collection, the next step is to analyze the data to identify trends, patterns, and insights. This analysis can involve statistical methods for quantitative data or qualitative techniques for open-ended responses. Proper data analysis is critical for drawing meaningful conclusions.
Draw Conclusions and Make Recommendations Based on the data analysis, businesses can draw conclusions and make informed recommendations for future actions. These recommendations might include changes to product offerings, marketing strategies, or business operations. The goal is to use the insights gained from the research to drive business improvements and growth.
Continuously Monitor and AdaptMarkets are dynamic and constantly evolving. Therefore, it is important for businesses to continuously monitor their performance and adapt their strategies as needed to remain competitive. This ongoing process of monitoring and adaptation ensures that businesses can respond to market changes and emerging trends effectively.
Speak to Analyst for Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/109515
The fibrin sealants market report equips investors with the tools to enhance decision-making, explore a variety of investment opportunities, and achieve their financial objectives more efficiently. Moreover, the fibrin sealants market industry is experiencing rapid growth, fueled by factors detailed in the report, with significant expansion anticipated during the forecast period.
Our report offers valuable insights for stakeholders, including healthcare providers, policymakers, and investors, enabling them to make informed decisions and capitalize on market trends. Through comprehensive analysis and data-driven insights, we aim to assist stakeholders in navigating the complexities of the healthcare sector, fostering innovation, and achieving improved patient outcomes and sustainable growth.
Quick Buy - Resuscitation Devices Market Report: https://www.fortunebusinessinsights.com/checkout-page/109515
Key questions answered in this report
Q.1. What is the estimated Resuscitation Devices Market size and growth rate for 2032?
Q.2. What are market trends of the Resuscitation Devices Market?
Q.3. What factors are fueling the growth of this Resuscitation Devices Market?
Q.4. What challenges are facing the Resuscitation Devices Market?
Q.5. Who are the primary key players in this market?
Q.6. What threats and opportunities do these key players encounter?
0 notes
Text
The Fibrin Sealant Market in 2023 is US$ 1.32 billion, and is expected to reach US$ 2.78 billion by 2031 at a CAGR of 9.72%.
0 notes
Text
0 notes
Text
Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022
Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022
The global plasmapheresis market will grow at a CAGR of 8.3% during the forecast period to reach USD 1,285.3 million by 2022, according to this latest publication from Meticulous Research®. The global plasmapheresis market is driven by increasing demand for source plasma from biopharmaceutical companies, increasing the incidence of autoimmune diseases, and favorable reimbursement for therapeutic plasmapheresis procedure. However, the high cost of plasmapheresis devices & procedures and lack of awareness about apheresis collection among the population in emerging countries is expected to hamper the growth of plasmapheresis market during the forecast period.
Market Segmentation
Global plasmapheresis market is segmented by product type (instrument and disposables), by technology (membrane filtration and centrifugation), by applications (therapeutic plasmapheresis and source plasma collection), by end user (biopharmaceutical companies, hospitals & clinics, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Source plasma collection/donor plasmapheresis segment dominates the global plasmapheresis market and is also expected to increase significantly in the next 5-10 years. The large share of this segment is mainly attributed to increasing demand of source plasma from plasma fractionation industry and rising demand for plasma for transfusion in a patient with various diseases.
Geographic Overview
Geographically, the global plasmapheresis market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global plasmapheresis market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher adoption of plasmapheresis for source plasma collection in the U.S. & Canada, increasing incidence of autoimmune disorders, well-established healthcare system, and favorable reimbursement in the U.S. for TPE procedures performed in hospitals. However, Asian countries are slated to register the fastest growth during the forecast period, owing to the rising healthcare spending, rising living standards, increasing awareness about plasmapheresis procedure, and growing plasma fractionation industry.
Key players
The global plasmapheresis market is oligopolies with top three players accounting for major share of the market in 2016. The major players providing plasmapheresis instrument and disposables in the global plasmapheresis market are B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation (Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co., Ltd. (China).
Scope of the Report:
Plasma Fractionation Market, by Product
Immunoglobulins
Intravenous Immunoglobulins (IVIg)
Subcutaneous Immunoglobulins (SCIg)
Intramuscular Immunoglobulins (IMIg)
Coagulation Factors
Albumin
Protease Inhibitors
Other Products
Note: Other plasma-derived products include fibrin, sealant, and plasma
Plasma Fractionation Market, by Application
Immunology
Hematology
Neurology
Critical Care
Hematology-oncology
Rheumatology & Orthopedics
Other Applications
Note: Other applications include the management of respiratory diseases and wound healing.
Plasma Fractionation Market, by End User
Hospitals & Clinics
Clinical Research Laboratories
Academic & Research Institutes
Plasma Fractionation Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific
China
Japan
India
Australia
Indonesia
Vietnam
Thailand
Malaysia
Rest of Asia-Pacific (RoAPAC)
Latin America
Brazil
Mexico
Columbia
Peru
Rest of Latin America (RoLATM)
Middle East & Africa
South Africa
Rest of Middle East & Africa
Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation-market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11-2022
0 notes
Text
Fibrin Surgical Sealant And Adhesive Market Enhancements and Demand Analysis 2022 to 2029
Fibrin Surgical Sealant And Adhesive Market Overview
The Research report on Fibrin Surgical Sealant And Adhesive contains all relevant information. By providing its clients with accurate data, it provides the market outlook and aids in the making of crucial decisions. The market size, share, dynamics, and forecast for major segments and sub-segments are provided in this report, which combines primary and secondary research. This market research study keeps track of all the latest advancements and changes in the industry. It gives the data regarding the obstacles while establishing the business and guides to overcome the upcoming challenges and obstacles.
Get a Sample copy of the report:
https://pharmaresearchconsulting.com/reports/fibrin-surgical-sealant-and-adhesive-market-global-growth-trends-and-forecast-2022-2029-by-type-polypeptide-protein-based-sealants-and-adhesives-polysaccharide-based-sealants-and-adhesives-by-application-by-regions
Get in Touch with Us: -
Phone No.+1 (704) 266-3234
Mail to: [email protected]
0 notes
Text
Fibrin Sealants Market By Forecast To 2026 With Covered Top Companies
The Fibrin Sealants Market has been anticipated to grow at a significant speed in the forthcoming years. Fibrin Sealants Market report is an excellent report that makes it possible to the healthcare industry to take strategic decisions and achieve growth objectives. This report also provides the company profile, product specifications, production value, contact information of manufacturer and market shares for company. For a better understanding of the market and leading business growth, Fibrin Sealants Market report is an ideal solution. This market analysis report gives clear idea on various segments that are relied upon to observe the quickest business development amid the estimate forecast frame.
The global fibrin sealants market size stood at USD 701.4 million in 2018 and is projected to reach USD 1,156.6 million by 2026, exhibiting a CAGR of 6.6% during the forecast period.
Get Sample PDF with Latest Trends:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100316
Drivers & Restraints
Increasing number of complex surgeries such as cardiac surgeries across the globe owing to rising prevalence of cardiac diseases in developing countries will contribute to rising adoption of hemostats during the forecast period. According to the America Hospital Association survey (2014), an estimated 17.2 million ambulatory hospital visits or inpatient stays required invasive, therapeutic surgery in the United States.
Reasons to Purchase Fibrin Sealants Market Report:
Current and future of Fibrin Sealants Market outlook in the developed and emerging markets.
The segment that is expected to dominate Fibrin Sealants Market.
Regions that are expected to witness the fastest growth during the forecast period.
Identify the latest developments, Fibrin Sealants Market shares, and strategies employed by the major market players.
It provides a forward-looking perspective on changing variables that are driving or controlling business development.
It provides a forecast based on how the Fibrin Sealants Market is to evolve.
To Purchase Report, Click Here:
https://www.fortunebusinessinsights.com/checkout-page/100316
COVID-19 Impact Analysis:
In this report, the pre-and post-COVID impact on the market growth and development is well depicted for better understanding of the Fibrin Sealants Market based on the financial and industrial analysis. The COVID epidemic has affected a number of Fibrin Sealants Market is no challenge. However, the dominating players of the market are adamant to adopt new strategies and look for new funding resources to overcome the rising obstacles in the market growth.
Related Reports:
Camellia Oil Market
Mica Paper Market Size
Cyclopentanone Market
Acetylcysteine Market Size
https://www.globenewswire.com/en/news-release/2022/03/16/2404166/0/en/Dental-CAD-CAM-Market-Size-2022-2029-worth-USD-4-94-Billion-exhibiting-a-CAGR-of-8-9.html
https://www.globenewswire.com/news-release/2022/03/30/2412758/0/en/US-Hearing-Aids-Market-Size-2022-2029-worth-USD-5-86-Billion-exhibiting-a-CAGR-of-7-8.html
https://www.globenewswire.com/news-release/2022/04/06/2417487/0/en/Medical-Tape-Market-Size-2022-2028-worth-USD-1-61-Billion-exhibiting-a-CAGR-of-5-0.html
https://www.globenewswire.com/news-release/2022/04/11/2419852/0/en/Europe-CRO-Services-Market-Size-2022-2029-worth-USD-35-91-Billion-exhibiting-a-CAGR-of-9-0.html
0 notes
Text
Bleeding Disorders Treatment Market Analysis, Industry Demand, Scope, Future Growth, Regional Trend and Business Prospect by Forecast to 2027
Market Synopsis:
The bleeding disorder treatment industry is largely bolstered by the expanding patient pool, mounting awareness about the available treatment options, and the supportive compensation policies. Expiry of patents belonging to major brands can also present opportunities to generic drug manufacturers to make their foray into the bleeding disorder therapeutics market. the demand for bleeding disorder treatment options is quite robust in western economies in Europe and North America, in view of the exorbitant rates of the branded drugs. The demand for low-priced drugs is growing in developing and underdeveloped countries, given the reduced purchasing capacity of the patients in terms of medical treatment.
The Bleeding Disorders Treatment Market Share is expected to register a growth of significant CAGR 10.90% during the forecast period.
The American Society of Hematology reveals that in the year 2016, close to 20,000 Americans had hemophilia, with the prevalence higher in males. Hemophilia is a type of bleeding disorder that is rare and has been escalating at an alarming rate worldwide. Meanwhile, the burden of von Willebrand disease has been growing rapidly as well, emerging as one of the most common bleeding disorders in the United States resulting from clotting proteins.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6592
Competitive Dashboard:
Shire Plc
Bayer Pharmaceuticals
Novo Nordisk A/S
Pfizer Inc.
Biogen Inc.
CSL Behring
Grifols
Octapharma
Sun Pharmaceutical Industries Ltd.
BDI Pharma
Ferring Pharmaceuticals
Others
Global Bleeding Disorders Treatment Market: Segmental Analysis:
Bleeding Disorders Treatment Market, by Type
Hemophilia A
Hemophilia B
Von Willebrand Disease (vWD)
Others
Bleeding Disorders Treatment Market, by Drug Class
Plasma-derived coagulation factor concentrates market
Global recombinant coagulation factor concentrate market
Global others bleeding disorders treatment market
Bleeding Disorders Treatment Market, by Treatment
Medication
Desmopressin (DDAVP)
Hormone replacement therapy
Contraceptives
Anti-fibrinolytic/clot-stabilizing drugs
Fibrin sealants
Drugs applied to cuts
Pipeline analysis (phase I, phase II and phase III clinical trials)
Bleeding Disorders Treatment Market, by End-Users
Hospitals
Clinics
Research Institutes
Others
Regional Insights:
Geographically, the global bleeding disorders treatment market span across regions namely, Europe, America, Asia-Pacific, and the Middle East and Africa.
Among all the regions, the North American region is predicted to occupy the largest market share. The growth is credited to the early adoption of advanced medical technologies, and constant development by the major companies operating into the drugs. As per the Hemophilia Federation of America, more than 20,000 people are affected by hemophilia.
The European region occupies the second largest market share in the global market owing to factors such as advancement of technology, augmenting expenses in research, the necessity for effective and innovative therapies, and the decline in human health. As per Statista, approximately 149,764 people were diagnosed with hemophilia A. More than 10,811 people were diagnosed with other platelet disorders in 2016.
The Asia-Pacific region is likely to experience significant growth in the coming years owing to access to optimal treatment facilities. Additional factors gearing up the market growth are augmenting demand for government initiatives, high adoption rate, advanced technology, and increasing expenditure on healthcare. For instance, as per the annual report survey of 2015 provided by the World Federation of Hemophilia, around 17,346 million people are suffering from hemophilia.
Meanwhile, the Middle East & Africa occupies the smallest share owing to an underdeveloped healthcare sector, poor medical facilities, and a dearth of technical knowledge.
Industry Updates:
February 07, 2019: Roche has recently announced that it has joined the World Federation of Hemophilia Humanitarian Aid Program. They have taken the initiative in order to change the lack of access to treatment and care for people suffering from inherited bleeding disorders in developing countries.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/bleeding-disorders-treatment-market-6592
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
0 notes
Text
Global Surgical Sealants & Adhesives Market Study, 2014-2030
Prismane Consulting is pleased to publish its Surgical Sealants & Adhesives Market Market Study Report which includes historic and current market situation of Surgical Sealants & Adhesives Market across several end-use industries.
Request Sample Report :
https://prismaneconsulting.com/report_request_sample?_token=GQpqeabK7q7DXVJNPgJtvJL5dHPpxnearbTIOnO0&report_id=90
This market study describes the global Surgical Sealants & Adhesives Market market, with focus on major countries and their subsequent demand across different applications and sub-applications. The study covers demand-supply analysis for regions including North America, Western Europe, Central & Eastern Europe, Central & South America, Asia-Pacific, Middle East and Africa and major countries like the U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Russia, Poland, Turkey, China, Japan, India, South Korea, Thailand, Taiwan, South Africa, and Saudi Arabia. The market is segmented based on end-use which includes Cardiovascular, Surgery, Orthopedic, and others.Surgical Sealants & Adhesives Market Production capacity expansions, force majeure, de-bottlenecks, plant shutdowns and new product developments have been considered in the report.
Surgical Sealants & Adhesives Market demand patterns are dramatically different between various regions and countries. In the areas with mature economies, demand growth for Surgical Sealants & Adhesives Market is expected to fall well below global averages primarily due to the geographic shift of many manufacturing industries to areas of lower labor costs such as China, India, and the ASEAN region.
The primary driver for the growth in demand of Surgical Sealants & Adhesives Market in Asia has been the migration of labor-intensive downstream conversion industries from developed high labor cost regions like North America and Western Europe.
Topics Covered
The report covers the following topics:
Surgical Sealants & Adhesives Market Market data in term of volume and value for each end-use at regional and country level
Surgical Sealants & Adhesives Market Market analysis for production, capacity, demand, supply, trade, and utilization rates at regional and country level
Trade balance and target markets for current situation, new expansions, or new projects
Business opportunity assessment
Macro-economic factors like GDP, population, and world economic integration
Strategic issues and recommendations
Strategic recommendations for vendors, and industry stakeholders
Market analysis and forecasts (short-, mid- and long-term forecast) from 2015 till 2030
Surgical Sealants & Adhesives Market Market: Applications Covered
Global Surgical Sealants & Adhesives Demand Analysis By Type,
By Applications, (Volume, Value) (2014–2030)
Strategic Issues
Demand Analysis and Forecast (2014 – 2030)
Demand
Demand Growth Rate (%)
Driving Force Analysis
Global Surgical Sealants & Adhesives Market, By Type
Natural Polymer Based
- Fibrin Based
- Collagen Based
- Albumin Based
Synthetic Polymer Based
- Polyurethane Based
- Polyethylene Glycol Based
- Polyester Based
Cyanoacrylate Sealants
Others
Global Surgical Sealants & Adhesives Market, By Application
Central Nervous System
Cardiovascular
Surgery
Orthopedic
Others
Surgical Sealants & Adhesives MarketMarket: Regions covered
- Asia Pacific
- Eastern Europe
- Central & South America
- Middle East & Africa
- North America
- Western Europe
Key Questions Answered
The Global Surgical Sealants & Adhesives Market Market study answers the following key questions:
How big is the Surgical Sealants & Adhesives Marketmarket?
How is the Surgical Sealants & Adhesives Market market evolving by demand-supply, segment, and region?
What will the Surgical Sealants & Adhesives Market market size be in 2030 and at what rate will it grow?
What trends, challenges and barriers are influencing its growth?
Who are the key manufacturers and what are their shares in different region?
What opportunities and target markets exist for Surgical Sealants & Adhesives Market
Buy This Report :
https://prismaneconsulting.com/checkout?_token=GQpqeabK7q7DXVJNPgJtvJL5dHPpxnearbTIOnO0&report_id=90&single_user_license=Single
About Prismane Consulting
Prismane Consulting is a unique consulting and market research firm providing management, economic and technical expertise across the global Chemicals, Petrochemicals, Polymers, Materials and Energy value chain. The company has been advising clients on their key strategic issues solving their toughest and most critical business problems. We have helped some of the fortune 500 companies develop their strategic plans by tracking and interpreting market dynamics.
Prismane consulting has completed several multi-client studies and projects. It offers Market Studies, World Analysis and Strategy Reports related to Refining, Chemicals, Petrochemicals, Plastic & Polymers and Materials. For update on the annual subscription (monthly, quarterly, and annually) on the chemicals industry, please write to [email protected]
Contact Us:
Mr. Tejas Shah
Chemicals & Energy, Prismane Consulting
Tel: +91-20-67277711/12
Email: [email protected]
0 notes
Text
Hemostasis & Tissue Sealing Agents Market
Market Overview
The Global "Hemostasis & Tissue Sealing Agents Market" is expected to grow at a CAGR of 8.3% in the forecast period (2021-2028).
Hemostasis is a process that stops bleeding by keeping the blood within the damaged blood vessel. Hemostatic agents are used to achieve hemostasis by reducing during surgical operations. These agents help in rapid hemostasis, have shorter operation time, decrease healing time. Hemostatic agents achieve hemostasis through different mechanisms, which include concentrating coagulation factors, adhesion to the tissues.
Download Free Samples @ https://www.datamintelligence.com/download-sample/hemostasis-tissue-sealing-agents-market
Market Dynamics
The global hemostasis & tissue sealing agents market is primarily driven by the rising number of surgeries and increasing demand for minimally invasive surgeries.
In multiple conditions of surgeries such as cardiovascular and endoscopic procedures, hemostatic agents are preferred over wound closure methods owing to the quick recovery and the difficulty to work in sensitive organs. Also, there have been many cases of traumas, deaths due to hemorrhage conditions, and the ensuing excessive bleeding.
For instance, according to the U.S. National Library of Medicine, 3792 clinical studies related to hemorrhage conditions are conducted worldwide. Out of these studies, 1,326 studies are noted to be done in the North America region, and the U.S. alone has 1,104 studies, while Europe is noted to conduct 1,194 studies.
However, the lack of proper reimbursements for these products will restrain the growth of hemostasis and tissue sealing agents.
Market Segmentation Analysis
Urology is expected to hold the highest share in the therapeutic area segment owing to the increasing outpatient surgeries. A variety of hemostatic and tissue sealants are available for performing urologic surgeries.
According to the U.S. National Library of Medicine, 26% of urology procedures were being performed as outpatients in 1987, and this increased to 51% by 2017.
Fibrin is expected to have the largest share in the class segment of the global hemostasis & tissue sealing agents market owing to the multiple areas of applications and great cost-efficiency.
For example, Fibrin glue products are approved by the U.S. FDA in 1998 to help in reinforcement of colonic anastomoses, splenic trauma, and cardiothoracic surgery. The product offers topical hemostasis, sealant properties, and promotes tissue approximation. In the presence of thrombin, fibrinogen is converted to fibrin, which further stabilizes the clot.
Geographical Share
North America holds the major share of hemostasis & tissue sealing agents market owing to the high prevalence of chronic diseases that require surgeries.
According to the Centers for Disease Control and Prevention (CDC), In the U.S., 6 out of 10 Adults have a chronic disease, of which 4 in 10 Adults have two or more diseases.
Europe also holds a significant share owing to the growing preference for technologically advanced sealing agents in the region.
For example, on 29th November 2018, the scientists of Lobachevsky University launched a unique hemostatic agent called Tectum that is used in emergency and military medicine.
On 3rd April 2017, Baxter International has launched FLOSEAL Full Sterile Preparation (FSP), an improved design of FLOSEAL hemostatic Matrix which was only available in Europe, but they have been supplied worldwide from 2019.
View Full Report @ https://www.datamintelligence.com/research-report/hemostasis-tissue-sealing-agents-market
Competitive Trends
The strategies used by key players include mergers and acquisitions, partnerships, and product launches to expand and stand out as strong competitors in the market. New product launches along with an increased focus on R&D are other ways the leading players improve their market presence. The key players in the hemostasis & tissue sealing agents’ market are Pfizer Inc., Johnson & Johnson, Cohera Medical, Medafor, Zimmer Biomet, King Pharmaceuticals Inc., ZymoGenetics, Baxter Healthcare Corporation, CryoLife, Integra LifeSciences Corporation, and B. Braun.
On 31st January 2019, Advanced Medical solutions group Plc, an advanced wound care specialist company acquired Sealantis Limited, a developer of an alginate-based tissue adhesive technology platform, for 25 USD Million.
On 9th April 2019, Baxter International, a global leader in advancing surgical innovation, received the U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix. This next generation of Floseal has 20 percent fewer components and steps to prepare, making it faster and convenient for usage.
On 8th January 2018, Baxter International has entered into an agreement with Mallinckrodt plc to acquire two hemostat and sealant products. The products are RECOTHROM Thrombin topical, recombinant thrombin, and PREVELEAK Surgical Sealant, which is used in vascular reconstruction.
For Enquiry @ https://www.datamintelligence.com/enquiry/hemostasis-tissue-sealing-agents-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866
Website: www.datamintelligence.com
0 notes
Text
Surgical Glue Market Outlook, Trend, Growth and Share Estimation Analysis
Surgical Glue Market: Introduction
Transparency Market Research has published a new report titled ‘Surgical Glue Market ’. According to the report, the global surgical glue market was valued at approximately ~US$ 1.8 Bn in 2018. It is expected to expand at a CAGR of ~5% during the forecast period from 2019 to 2027.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74372
Wound closure is one of the vital steps of surgical procedure, whereas suturing is termed as the most widely used method of wound closure. The process of suturing usually prolongs the length of surgery and increases the patient’s risk of anesthesia awareness. It has several disadvantages, including iatrogenic trauma to the tissue, pain, increased risk of infection and inflammation, delayed healing, and inability to provide an immediate seal. Nowadays, interest in surgical glues as a substitute to suturing has been increasing. Rise in need, application, and availability of surgical glues for different surgical subspecialties has been observed. A significant number of surgical glues functionally depend on a physiologic coagulation cascade. Two of the essential components of the coagulation cascade are thrombin and fibrinogen. In the presence of calcium ions, thrombin cleaves the fibrinogen chains. The resulting fibrinogen monomers eventually polymerize and form a fibrin clot. These steps are independent of the coagulation pathway and can be reproduced artificially. The rate of the clot formation increases with thrombin concentration. The strength of the clot, on the other hand, depends on the concentration of fibrinogen.
The cyanoacrylates sub-segment held a major share of the synthetic & semi-synthetic adhesives and sealants product segment of the surgical glue market in 2018. This sub-segment is likely to maintain its dominance during the forecast period, owing to the increase in its usage in different types of surgeries for various indication. User-friendliness and safe application of surgical glues have resulted in their greater adoption, as compared to traditional wound closure methods. The cyanoacrylates sub-segment is anticipated to grow at a rapid pace during the forecast period. The fibrin sealants sub-segment held a significant share of the natural adhesives and sealants product segment of the surgical glue market and it is likely to expand at a moderate CAGR between 2019 and 2027. The expansion of this sub-segment can be attributed to the rise in surgeries.
Request a Sample of Surgical Glue Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74372
In terms of indication, the hemostasis segment held a major share of the global surgical glue market in 2018. This can be attributed to their advantages such as easy-to-use, and no trauma to the internal body organs and vessels. Moreover, the ergonomic design of these products offers high stability.
Based on application, the cardiovascular surgery segment held a major share of the global surgical glue market in 2018. This segment is likely to maintain its dominance during the forecast period. Rise in incidence of diseases correspondingly drives the number of surgical procedures performed, thereby, boosting the usage of surgical glues in surgeries and mainly, cardiovascular procedures globally. It has been a standard procedure in most medical centers providing surgical services for several years. Both the range and the number of surgical procedures performed are constantly increasing, which is driving the segment.
In terms of end user, the hospitals segment held a major share of the surgical glue market in 2018. Hospital providers are more likely to have experience with trauma patients and emergency measures than surgery center providers. Ambulatory surgery centers (ASCs) are outpatient facilities that offer surgical procedures to patients at reduced costs, often with greater scheduling flexibility than hospitals.
Request for Analysis of COVID19 Impact on Surgical Glue Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74372
Surgical Glue Market: Prominent Regions
North America held a major share of the global surgical glue market in 2018. Presence of key market players, a highly structured healthcare industry, and key developments by market players are the primary driving factors for the market in the region. Rise in awareness regarding benefits of surgeries and procedures and increase in healthcare expenditure are propelling the growth of the regional market. These factors are anticipated to drive the surgical glue market in the region.
Europe held the second largest share of the global surgical glue market in 2018. The growth of the surgical glue market in the region can be attributed to the increase in prevalence of chronic diseases and a well-developed healthcare sector in the region. Asia Pacific accounted for a significant share of the surgical glue market in 2018 and the market in the region is expected to grow at a rapid pace during the forecast period. Increase in the number of people with cardiovascular diseases, product approvals, and rise in awareness about cardiovascular diseases are factors anticipated to fuel the growth of the surgical glue market in the region.
Buy now Surgical Glue Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=74372<ype=S
Surgical Glue Market: Key Players
Key players are expanding their global footprint to strengthen their position in the surgical glue market. Increase in the number of patient population and development of new effective surgical glue offer lucrative opportunities to key players to increase their share in the surgical glue market. Manufacturers are engaging in new product development, collaborations, and distribution. In January 2017, Johnson & Johnson acquired Action Ltd. This acquisition enabled the company to enhance its cardiovascular and metabolic therapeutic segments portfolios.
Prominent players operating in the global surgical glue market include Baxter, Braun Melsungen, Cardinal Health, CR. Bard, Johnson & Johnson, OptMed, Inc., Advanced Medical Solutions Group plc, CryoLife, Integra LifeSciences, and Medtronic.
More Trending Reports by Transparency Market Research:
Bioanalytical Services Market Service providers have reaped lucrative revenue gains from the widespread uptake of immunochemistry services. In recent months, the demand for bioanalytical services for the development of drugs and vaccines for COVID-19 infection has accelerated the growth prospects of the bioanalytical services market.
Baby & Pregnancy Skincare Products Market The high competitiveness in the market is influencing the decisions of buyers. Consumers are demanding products that are free of toxic mineral oils, parabens, triclosan, harsh perfumes, and 1,4-dioxane. As a result, firms are leveraging social media, influencer marketing, and other promotional methods to attain market dominance.
Continence Care Market North America holds substantial revenue in the continence care market. The availability of a range of continence care products, along with recent development of electric stimulation devices in the U.S. spells growth in the continence care market of the region. The availability of reimbursement schemes such as manual electric stimulation of the pelvic floor for 15 minutes that is covered under the CPT code of 97032 of the U.S. reimbursement program stokes growth.
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
0 notes
Link
The global Fibrin Sealants market size is expected to be worth around US$ 1.4 Billion by 2027, according to a new report by Nova One Advisor .
The global Fibrin Sealants market size was valued at US$ 900.8 Million in 2020 and is anticipated to grow at a CAGR of 6.1% during forecast period 2021 to 2027.
0 notes
Text
Tissue Sealants Market Driving Innovations, Future Growth and Industry Share Forecast to 2028
Qurate Business Intelligence introducing new research on Global Tissue Sealants covering micro level of analysis by competitors and key business segments (2022-2028). The Global Tissue Sealants explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists both qualitative and quantitative detailing.
Major Key players profiled in the study
CSL Behring
Advanced Medical Solutions Group
C. R. Bard
Johnson and Johnson
Cryolife
Integra LifeSciences
Baxter International
Cardinal Health
B. Braun
Cohera Medical
Get Free Sample Report + All Related Table and Graphs @ https://www.qurateresearch.com/report/sample/HnM/global-tissue-sealants-market/QBI-MR-HnM-1096186
Key Points in the Market: The key features of this Tissue Sealants market report includes production, production rate, revenue, price, cost, market share, capacity, capacity utilization rate, import/export, supply/demand, and gross margin. Key market dynamics plus market segments and sub-segments are covered.
Key Growths in the Market: This section of the report incorporates the essential enhancements of the marker that contains assertions, coordinated efforts, R&D, new item dispatch, joint ventures, and associations of leading participants working in the market.
on the basis of types, the Tissue Sealants market from 2015 to 2025 is primarily split into:
Fibrin
Synthetic Sealant
on the basis of applications, the Tissue Sealants market from 2015 to 2025 covers:
Hospitals
Research Institutions
Interpretative Tools in the Market: The report integrates the entirely examined and evaluated information of the prominent players and their position in the market by methods for various descriptive tools. The methodical tools including SWOT analysis, Porter's five forces analysis, and investment return examination were used while breaking down the development of the key players performing in the market.
Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Basic Questions Answered
*who are the key market players in the Tissue Sealants Market?
*Which are the major regions for dissimilar trades that are expected to eyewitness astonishing growth for the
*What are the regional growth trends and the leading revenue-generating regions for the Tissue Sealants Market?
*What are the major Product Type of Tissue Sealants?
*What are the major applications of Tissue Sealants?
*Which Tissue Sealants technologies will top the market in next 5 years?
Table of Content
Chapter One: Industry Overview
Chapter Two: Major Segmentation (Classification, Application and etc.) Analysis
Chapter Three: Production Market Analysis
Chapter Four: Sales Market Analysis
Chapter Five: Consumption Market Analysis
Chapter Six: Production, Sales and Consumption Market Comparison Analysis
Chapter Seven: Major Manufacturers Production and Sales Market Comparison Analysis
Chapter Eight: Competition Analysis by Players
Chapter Nine: Marketing Channel Analysis
Chapter Ten: New Project Investment Feasibility Analysis
Chapter Eleven: Manufacturing Cost Analysis
Chapter Twelve: Industrial Chain, Sourcing Strategy and Downstream Buyers
Buy the Full Research report of Global Tissue Sealants Market@: https://www.qurateresearch.com/report/buy/HnM/global-tissue-sealants-market/QBI-MR-HnM-1096186
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
A free report data (as a form of Excel Datasheet) will also be provided upon request along with a new purchase.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
(*If you have any special requirements, please let us know and we will offer you the report as you want.)
Contact Us:
Qurate Business Intelligence delivers unique Market study with COVID-19 Impact research solutions to its customers and help them to get equipped with refined information and Market study with COVID-19 Impact insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.
Web: www.qurateresearch.com
E-mail: [email protected]
Ph: US – +13393375221, IN – +919881074592
0 notes
Text
Surgical Sealants and Adhesives Market Worth $2.8 Billion by 2025 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Surgical Sealants and Adhesives Market by Product (Natural (Fibrin, Collagen, Gelatin), Synthetic (Hydrogel)), Indication (Tissue Sealing, Tissue Engineering), Application (CNS, Cardiovascular, Cosmetic Surgery), End User - Global Forecast to 2025", published by MarketsandMarkets™, the Surgical Sealants and Adhesives Market is expected to reach USD 2.8 billion in 2025 from USD 1.9 billion in 2020, at a CAGR of 8.4% during the forecast period.
Request for PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38230314
The growing concerns regarding the effective management of blood loss in patients during surgeries and trauma, surgical sealants and adhesives have become an integral part of medical procedures. Also, the growing prevalence and incidence rates of various disorders such as obesity and CVDs; increasing incidence of trauma; growth in the number of accidents and sports-related injuries, which has led to an increase in surgical procedures being performed across the globe are factors driving the market growth. Better cosmetic outcomes are also increasing the adoption of surgical sealants and adhesives in cosmetic procedures across the globe. The growing prominence of adhesive dentistry also offers significant growth opportunities for players operating in this space.
By product, the natural/biological sealants and adhesives segment is expected to account for the largest share of the Surgical Sealants Market
Based on product, the Surgical Adhesives Market is segmented into natural/biological sealants and adhesives and synthetic & semisynthetic sealants and adhesives. The natural/biological sealants and adhesives segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the fact that sealants derived from natural polymers provide superior biocompatibility, reduced immune response, and in vivo degradability as compared to synthetic sealants; and are used to repair injured tissues and reinforce surgical wounds, having replaced common suturing techniques.
Browse in-depth TOC on "Surgical Sealants and Adhesives Market"
264 – Tables
49 – Figures
273 – Pages
Tissue sealing dominated the Surgical Adhesives Market in 2019
By indication, the tissue sealing segment accounted for the largest share of the Surgical Sealants Market, followed by surgical hemostasis and tissue engineering in 2019. The large share of the tissue sealing segment can be attributed to the increasing use of tissue sealants and glues with the increasing number of surgeries being performed annually the need to manage blood loss during these procedures, and the growing number of people suffering from sports-related injuries.
The cardiovascular surgery segment is expected to witness the rising adoption of biosurgery products during the forecast period
By application, the cardiovascular surgery segment accounted for the largest share of the Surgical Adhesives Market, followed by general surgery, and CNS surgery in 2019. The large share of the cardiovascular surgery segment is attributed to the increasing use of sealants and adhesives in CVD surgeries to overcome the challenges such as friable tissue, coagulopathy, poor visualization of the surgical field, and poor bleeding-site accessibility. Surgical sealants also help stop bleeding from adhesions at the time of re-operative cardiac surgery and from diffuse surfaces with capillary bleeding. With the increasing incidence of CVDs due to rising obesity and lifestyle-related disorders, the diagnostic and therapeutic procedures are set to increase, thereby leading to the growing adoption of sealants and adhesives.
Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=38230314
Hospitals to increase the adoption of biosurgery products with increasing surgical procedures being undertaken
Based on end users, the Surgical Sealants And Adhesives Market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, burn care centers, and research institutes). The hospitals segment is estimated to grow at the highest CAGR during the forecast period. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the rising adoption of sealants and adhesives by surgeons. The low cost of these products along with their ease of use and lower risk of complications, offer significant advantages, further supporting market growth.
North America to dominate the Surgical Sealants Market during the forecast period
In 2019, North America dominated the global Surgical Adhesives Market, followed by Europe. The large share of North America can be attributed to the significant growth opportunities for players operating in the market owing to the presence of many large hospitals and an increasing number of surgical procedures in this region. Moreover, a number of major global players are based in the US, owing to which the US is a center for innovation in the market.
The prominent players in this Surgical Sealants Market are Baxter International, Inc. (US), CryoLife, Inc. (US), Becton, Dickinson and Company [C.R Bard (US)], Ethicon, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Integra Lifesciences Holdings Corporation (US), Medline Industries, Inc. (US), Adhezion Biomedical, LLC (US), Tricol Biomedical, Inc. (US), Vivostat A/S (Denmark), Advanced Medical Solutions Group plc (UK), Stryker Corporation (US), CSL Limited (Australia), Ocular Therapeutix, Inc. (US), MicroVal (France), GEM Srl (Italy), Hemostasis, LLC (US), Péters Surgical (France), and Tissuemed Ltd (UK).
0 notes
Text
0 notes
Text
Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022
Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022
The global plasmapheresis market will grow at a CAGR of 8.3% during the forecast period to reach USD 1,285.3 million by 2022, according to this latest publication from Meticulous Research®. The global plasmapheresis market is driven by increasing demand for source plasma from biopharmaceutical companies, increasing the incidence of autoimmune diseases, and favorable reimbursement for therapeutic plasmapheresis procedure. However, the high cost of plasmapheresis devices & procedures and lack of awareness about apheresis collection among the population in emerging countries is expected to hamper the growth of plasmapheresis market during the forecast period.
Market Segmentation
Global plasmapheresis market is segmented by product type (instrument and disposables), by technology (membrane filtration and centrifugation), by applications (therapeutic plasmapheresis and source plasma collection), by end user (biopharmaceutical companies, hospitals & clinics, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Source plasma collection/donor plasmapheresis segment dominates the global plasmapheresis market and is also expected to increase significantly in the next 5-10 years. The large share of this segment is mainly attributed to increasing demand of source plasma from plasma fractionation industry and rising demand for plasma for transfusion in a patient with various diseases.
Geographic Overview
Geographically, the global plasmapheresis market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global plasmapheresis market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher adoption of plasmapheresis for source plasma collection in the U.S. & Canada, increasing incidence of autoimmune disorders, well-established healthcare system, and favorable reimbursement in the U.S. for TPE procedures performed in hospitals. However, Asian countries are slated to register the fastest growth during the forecast period, owing to the rising healthcare spending, rising living standards, increasing awareness about plasmapheresis procedure, and growing plasma fractionation industry.
Key players
The global plasmapheresis market is oligopolies with top three players accounting for major share of the market in 2016. The major players providing plasmapheresis instrument and disposables in the global plasmapheresis market are B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation (Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co., Ltd. (China).
Scope of the Report:
Plasma Fractionation Market, by Product
Immunoglobulins
Intravenous Immunoglobulins (IVIg)
Subcutaneous Immunoglobulins (SCIg)
Intramuscular Immunoglobulins (IMIg)
Coagulation Factors
Albumin
Protease Inhibitors
Other Products
Note: Other plasma-derived products include fibrin, sealant, and plasma
Plasma Fractionation Market, by Application
Immunology
Hematology
Neurology
Critical Care
Hematology-oncology
Rheumatology & Orthopedics
Other Applications
Note: Other applications include the management of respiratory diseases and wound healing.
Plasma Fractionation Market, by End User
Hospitals & Clinics
Clinical Research Laboratories
Academic & Research Institutes
Plasma Fractionation Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific
China
Japan
India
Australia
Indonesia
Vietnam
Thailand
Malaysia
Rest of Asia-Pacific (RoAPAC)
Latin America
Brazil
Mexico
Columbia
Peru
Rest of Latin America (RoLATM)
Middle East & Africa
South Africa
Rest of Middle East & Africa
Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation-market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11-2022
0 notes
Last Seen Blogs
canonandme
A girl can dream
russellvedtarp
Untitled
omelettedraws
🌈✨omelettedraws✨🌈
virtualpizzacloud
Fun times
naomiinteal
NaomiInTeal